共 12 条
[1]
Cao JP, 1998, INT J TUBERC LUNG D, V2, P360
[2]
CASTELO A, 1989, LANCET, V2, P1173
[3]
VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY
[J].
LANCET,
1995, 346 (8986)
:1339-1345
[4]
Fox W, 1999, INT J TUBERC LUNG D, V3, pS231
[5]
Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295
[6]
RIFABUTIN FOR THE TREATMENT OF NEWLY-DIAGNOSED PULMONARY TUBERCULOSIS - A MULTINATIONAL, RANDOMIZED, COMPARATIVE-STUDY VERSUS RIFAMPICIN
[J].
TUBERCLE AND LUNG DISEASE,
1994, 75 (05)
:341-347
[9]
Relapse after short-course chemotherapy of patients with sputum smear-positive pulmonary tuberculosis under routine conditions with additional information on side effects and contact tracing
[J].
TUBERCLE AND LUNG DISEASE,
1996, 77 (05)
:425-428
[10]
Mathew R, 1997, INT J TUBERC LUNG D, V1, P509